Pfizer's Drug Distribution Deal Raises Concerns
The United Kingdom's competition regulator has revealed that exclusive drug distribution deals, like the one between Pfizer Inc. and Alliance Boots Plc, may potentially cost the country's nationalized health service hundreds...To view the full article, register now.
Already a subscriber? Click here to view full article